Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: Initial monotherapy outcomes at 12 months

Authors

Tracy Glauser, University of Cincinnati
Avital Cnaan, George Washington UniversityFollow
Shlomo Shinnar, Albert Einstein College of Medicine
Deborah G. Hirtz, National Institute of Neurological Disorders and Stroke, Bethesda, MD
Dennis Dlugos, Children's Hospital Philadelphia
David Masur, Albert Einstein College of Medicine
Peggy O. Clark, Albert Einstein College of Medicine
Peter Adamson, Children's Hospital PhiladelphiaFollow

Document Type

Journal Article

Publication Date

1-2013

Journal

Epilepsia

Volume

Volume 54, Issue 1

Inclusive Pages

141-155

Keywords

Anticonvulsants--therapeutic use; Epilepsy; Absence--drug therapy; Ethosuximide--therapeutic use; Triazines--therapeutic use; Valproic Acid--therapeutic use

Comments

This is a PubMed Central article. Click on link for full-text access.

APA Citation

Glauser, T.A., Cnaan, A., Shinnar, S., Hirtz, D.G., Dlugos, D., Masur, D., Clark, P.O., Adamson, P.C. (2013). Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia, 54(1), 141-155.

Peer Reviewed

1

Open Access

1